SNCA and Parkinson disease: Along with this, recent studies strongly demonstrated the specific binding of tetrameric α-synuclein to GM1 which promotes its α-helical conformation against the beta-sheet-rich state of α-synuclein that has been associated with its pathological aggregation in Parkinson’s disease [132,133,134].